COMP <GO>
HHS vs NFLX // ALTMAN Z-SCORE & DEBT/EQUITY
Harte Hanks Inc. (NASDAQ) VS. Netflix, Inc. (NASDAQ) • 15-METRIC TALLY: HHS 3
— NFLX 7
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: HHS
LAST: $3.87 (+0.26%) • MKT CAP: $28.8M
balance-sheet
14.61
LAST: $62.08 (+0.05%) • MKT CAP: $254.80B
balance-sheet
8.25
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HHS VS. NFLX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HHS | NFLX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 50.68% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.00% | 33.94% | -31.94 | NFLX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.5x | 16.2x | -7.70 | HHS | /valuation <GO> |
| Free Cash Flow Yield | -15.61% | 4.46% | -20.07 | NFLX | /fcf-yield <GO> |
| Operating Margin | 0.20% | 31.30% | -31.10 | NFLX | /operating-margins <GO> |
| Net Profit Margin | -0.50% | 29.69% | -30.19 | NFLX | /net-margins <GO> |
| Revenue Growth (YoY) | -13.90% | 14.65% | -28.55 | NFLX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 14.61 | 8.25 | +6.36 | HHS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 7/9 | -6.00 | NFLX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.26% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.4 | 31.6 | +4.80 | HHS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.41 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 16.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $28.8M | $254.80B | -$254.77B | NFLX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HHS REV | NFLX REV | HHS GROSS % | NFLX GROSS % | HHS FCF | NFLX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $159.6M | $45.18B | — | 48.5% | -$4.5M | $9.46B |
| FY 2024 | $185.2M | $39.00B | — | 46.1% | -$6.7M | $6.92B |
| FY 2023 | $191.5M | $33.72B | — | 41.5% | $10.5M | $6.93B |
| FY 2022 | — | $31.62B | — | 39.4% | — | $1.62B |
| FY 2021 | — | $29.70B | — | 41.6% | — | -$132.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HHS // BETA —
NFLX // BETA 1.41